SCHEMBL8055985

SCHEMBL8055985

C1CCC2C[N]CC2NC1

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
EPAS1 Q99814 1/20 0.36
HRH4 Q9H3N8 2/20 0.31
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL477175 0.93
SCHEMBL2095877 0.93
SCHEMBL477174 0.93
SCHEMBL3204034 0.93
SCHEMBL477140 0.83
SCHEMBL477173 0.83
SCHEMBL8044830 0.83 EPAS1 (0.34) EPAS1
SCHEMBL8062474 0.83 EPAS1 (0.34) EPAS1HRH4
SCHEMBL7856396 0.77 EPAS1 (0.32) EPAS1ALDH1A1
SCHEMBL7852425 0.76 EPAS1 (0.32) EPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 US disclosed